Sign In
Buy SIGA
$4.29
-0.0300 (-0.694%)
At Close: Jun 03, 2026
6 Stocks To Watch Amid Monkeypox Outbreak
05:14pm, Friday, 20'th May 2022
A Monkeypox outbreak has been reported in several European countries, two cases in Canada and one confirmed case in a man from Massachusetts. What's going on?
Monkeypox Fears Drive Smallpox Antiviral Makers Higher
12:38pm, Friday, 20'th May 2022 Zacks Investment Research
Emergent BioSolutions (EBS) stock was up almost 12% while SIGA Technologies (SIGA) rose 17.1% on Thursday.
Monkeypox Stocks: SIGA, EBS and TNXP Move Higher on Smallpox Vaccines, Treatments
11:34am, Friday, 20'th May 2022
Monkeypox stocks SIGA, EBS and TNXP are all advancing as fears mount over monkeypox. The disease is related to smallpox.
Monkeypox Fears Drive Smallpox Antiviral Makers Higher
09:47am, Friday, 20'th May 2022
Emergent BioSolutions (EBS) stock was up almost 12% while SIGA Technologies (SIGA) rose 17.1% on Thursday.
Why These 2 Nasdaq Stocks Soared Thursday
07:06pm, Thursday, 19'th May 2022 The Motley Fool
The tech-heavy index held up better than the rest of the market.
Why SIGA Technologies Shares Are Trading Higher Today?
03:28pm, Thursday, 19'th May 2022
The FDA approved the intravenous (IV) formulation of SIGA Technologies Inc's (NASDAQ: SIGA) TPOXX for smallpox. The oral formulation of TPOXX (tecovirimat) is approved in the US, Canada, and Europ
Why These 2 Nasdaq Stocks Soared Thursday
03:06pm, Thursday, 19'th May 2022
The tech-heavy index held up better than the rest of the market.
SIGA Receives Approval from the FDA for Intravenous (IV) Formulation of TPOXX® (tecovirimat)
11:30am, Thursday, 19'th May 2022 GlobeNewswire Inc.
- FDA approval provides an important option for those unable to take oral formulation of TPOXX - - FDA approval provides an important option for those unable to take oral formulation of TPOXX -
SIGA Technologies, Inc. (SIGA) CEO Phillip Gomez on Q1 2022 Results - Earnings Call Transcript
09:23am, Sunday, 08'th May 2022
SIGA Technologies, Inc. (NASDAQ:SIGA ) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Phillip Gomez - Chief Executive Officer Dan Luckshire - Chief Financial Officer Denn
SIGA Declares Special Dividend of $0.45 Per Share
11:30am, Thursday, 05'th May 2022 GlobeNewswire Inc.
NEW YORK, May 05, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that the Board of Directors declared a special di
3 Biotech Stocks Under $10 to Add to Your Buy List
07:17am, Tuesday, 26'th Apr 2022
These biotech stocks to buy are all profitable, which is important for investors looking to reduce their investment risk. The post 3 Biotech Stocks Under $10 to Add to Your Buy List appeared first on
SIGA Technologies, Inc. (SIGA) CEO Phillip Gomez on Q4 2021 Results - Earnings Call Transcript
10:04pm, Thursday, 03'rd Mar 2022
SIGA Technologies, Inc. (SIGA) CEO Phillip Gomez on Q4 2021 Results - Earnings Call Transcript
SIGA Technologies GAAP EPS of $0.98, revenue of $115.4M
09:13pm, Thursday, 03'rd Mar 2022 Seeking Alpha
SIGA Technologies press release (SIGA): Q4 GAAP EPS of $0.98.Revenue of $115.4M (+205.3% Y/Y).
SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2021
09:05pm, Thursday, 03'rd Mar 2022 GlobeNewswire Inc.
- Approximately $113 Million of U.S. Product Sales in 2021 –
SIGA Technologies FY 2021 Earnings Preview (NASDAQ:SIGA)
10:35pm, Wednesday, 02'nd Mar 2022 Seeking Alpha
SIGA Technologies (NASDAQ:SIGA) is scheduled to announce FY earnings results on Thursday, March 3rd, after market close.The consensus EPS Estimate is $0.88 (+23.9% Y/Y) and the…
